With Jaundiced EyesDURAND, Christine; SCHIFFER, Joshua T.The American journal of medicine. 2009, Vol 122, Num 1, pp 21-23, issn 0002-9343, 3 p.Article

Cases from the osler medical service at Johns Hopkins UniversitySCHIFFER, Joshua T; PARK, Cecelia; JEFFERSON, Brian K et al.The American journal of medicine. 2003, Vol 114, Num 1, pp 68-70, issn 0002-9343, 3 p.Article

Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS : A decision analysisSCHIFFER, Joshua T; STERLING, Timothy R.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 2, pp 229-234, issn 1525-4135, 6 p.Article

Equal HIV-1 Decay Kinetics in HSV-2-Infected and HSV-2-Uninfected Clinical Trial Participants Treated With Antiretroviral TherapyTHOMAS SCHOUTEN, Jeffrey; SCHIFFER, Joshua T.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 1, pp 68-71, issn 1525-4135, 4 p.Article

Cases from the Osler Medical Service at Johns Hopkins UniversitySCHIFFER, Joshua T; JEFFERSON, Brian K.The American journal of medicine. 2003, Vol 115, Num 5, pp 404-406, issn 0002-9343, 3 p.Article

Rapid Viral Expansion and Short Drug Half-Life Explain the Incomplete Effectiveness of Current Herpes Simplex Virus 2-Directed Antiviral AgentsSCHIFFER, Joshua T; SWAN, David A; COREY, Lawrence et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 5820-5829, issn 0066-4804, 10 p.Article

Population Level Impact of an Imperfect Prophylactic Vaccine for Herpes Simplex Virus-2ALSALLAQ, Ramzi A; SCHIFFER, Joshua T; LONGINI, Ira M et al.Sexually transmitted diseases. 2010, Vol 37, Num 5, pp 290-297, issn 0148-5717, 8 p.Article

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantationSCHIFFER, Joshua T; KIRBY, Kate; SANDMAIER, Brenda et al.Haematologica (Roma). 2009, Vol 94, Num 8, pp 1101-1108, issn 0390-6078, 8 p.Article

Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapySCHIFFER, Joshua T; MAGARET, Amalia; SELKE, Stacy et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 11, pp 2593-2600, issn 0305-7453, 8 p.Article

The Kinetics of Mucosal Herpes Simplex Virus―2 Infection in Humans: Evidence for Rapid Viral-Host InteractionsSCHIFFER, Joshua T; WALD, Anna; SELKE, Stacy et al.The Journal of infectious diseases. 2011, Vol 204, Num 4, pp 554-561, issn 0022-1899, 8 p.Article

Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trialsJOHNSTON, Christine; SARACINO, Misty; KUNTZ, Steve et al.Lancet (British edition). 2012, Vol 379, Num 9816, pp 641-647, issn 0140-6736, 7 p.Article

Peripheral Blood CD4 T-Cell and Plasmacytoid Dendritic Cell (pDC) Reactivity to Herpes Simplex Virus 2 and pDC Number Do Not Correlate with the Clinical or Virologic Severity of Recurrent Genital HerpesMOSS, Nicholas J; MAGARET, Amalia; LAING, Kerry J et al.Journal of virology. 2012, Vol 86, Num 18, pp 9952-9963, issn 0022-538X, 12 p.Article

Targeted DNA Mutagenesis for the Cure of Chronic Viral InfectionsSCHIFFER, Joshua T; AUBERT, Martine; WEBER, Nicholas D et al.Journal of virology. 2012, Vol 86, Num 17, pp 8920-8936, issn 0022-538X, 17 p.Article